Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07465926) titled 'Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3' on March 8.
Study Type: Observational
Primary Sponsor: Chung Shan Medical University
Condition:
Cardiovascular-kidney-metabolic Syndrome
Cardiovascular Disease Risk Factor
Kidney Disease
Type 2 Diabetes
Obesity & Overweight
Intervention:
Drug: GLP-1 receptor agonist
Recruitment Status: Not recruiting
Date of First Enrollment: January 1, 2017
Target Sample Size: 451036
To know more, visit https://clinicaltrials.gov/study/NCT07465926
Published by HT Digital Content Services with ...